Pfizer

Running trials

• Active, not recruiting

  Korean Post Marketing Surveillance for ELREXFIO (Elranatamab).

  NCT06581848· Source

• Recruiting

  Korea Xeljanz Post-marketing Surveillance for Juvenile Idiopathic Arthritis

  NCT05754710· Source

• Recruiting

  Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

  NCT05599412· Source

• Recruiting

  Korean Post-marketing Surveillance for Xeljanz XR

  NCT04876781· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Psoriatic arthritis2 recruiting
• Ankylosing spondylitis1 recruiting
• Lung cancer1 recruiting
• Rheumatoid arthritis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Atrial Fibrillation Data Linkage Non-Interventional Study

  NCT05810727· Source

• Completed

  Korean Post-marketing Surveillance Vyndamax® Capsules for the Treatment of Transthyretin Amyloid Cardiomyopathy

  NCT04801329· Source

• Completed

  Korea Post Marketing Surveillance (PMS) Study of Vizimpro

  NCT04721106· Source

• Completed

  Post Marketing Surveillance Study to Observe Safety and Efficacy of IBRANCE®

  NCT03445637· Source